Date of dispatch of this notice: 25/03/2020
Expire date: 27/04/2020
External Reference: 2020-299452
TED Reference: 2020/S 062-147608
Contract notice
Information
Published
Contract notice
Contract notice
Directive 2014/24/EU
Section I: Contracting authority
I.1)
Name and addresses
St James's Hospital
N/A
James Street
Dublin
Dublin 8
IE
Contact person:
Pat Sullivan
Telephone:
+353 14162468
E-mail:
pfsullivan@stjames.ie
Internet address(es):
Main address:
www.stjames.ie
Address of the buyer profile:
https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/395
I.3)
Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=164735&B=ETENDERS_SIMPLEAdditional information can be obtained from
the abovementioned address:
Tenders or requests to participate must be submitted
electronically via:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=164735&B=ETENDERS_SIMPLE
Tenders or requests to participate must be submitted
to the abovementioned address
I.4)
Type of the contracting authority
Body governed by public law
I.5)
Main activity
Health
Section II: Object
II.1)
Scope of the procurement
II.1.1)
Title
Invitation to tender for the Provision of Molecular Microbiology analysers for the Microbiology Department within St James’s Hospital Dublin
II.1.2)
Main CPV code
38000000
-
Laboratory, optical and precision equipments (excl. glasses)
II.1.3)
Type of contract
Supplies
II.1.4)
Short description
The Molecular Laboratory currently offers the following assays using a batch testing methodology (Abbott m2000sp/rt system):
• Chlamydia trachomatis and Neisseria gonorrhoeae (qualitative result) on both genital and non-genital samples (urines and swabs)
• Hepatitis B viral load (quantitative result) on plasma samples
The laboratory seeks to change the testing of these assays to a random access / continuous load instrument. In addition, it is proposed to also use the instrument for other testing to consolidate work onto one instrument. Proposed tests that may be prioritised include (but are not limited to):
• Mycoplasma genitalium
• Influenza A
• Influenza B
• Chlamydia trachomatis and Neisseria gonorrhoeae (qualitative result) on both genital and non-genital samples (urines and swabs)
• Hepatitis B viral load (quantitative result) on plasma samples
The laboratory seeks to change the testing of these assays to a random access / continuous load instrument. In addition, it is proposed to also use the instrument for other testing to consolidate work onto one instrument. Proposed tests that may be prioritised include (but are not limited to):
• Mycoplasma genitalium
• Influenza A
• Influenza B
II.1.5)
Estimated total value
Value excluding VAT: 2500000.00
EUR
II.1.6)
Information about lots
This contract is divided into lots:
no
II.2)
Description
II.2.2)
Additional CPV code(s)
33696500
-
Laboratory reagents
51430000
-
Installation services of laboratory equipment
II.2.3)
Place of performance
Main site or place of performance:
James Street
II.2.4)
Description of the procurement
The Molecular Laboratory currently offers the following assays using a batch testing methodology (Abbott m2000sp/rt system):
• Chlamydia trachomatis and Neisseria gonorrhoeae (qualitative result) on both genital and non-genital samples (urines and swabs)
• Hepatitis B viral load (quantitative result) on plasma samples
The laboratory seeks to change the testing of these assays to a random access / continuous load instrument. In addition, it is proposed to also use the instrument for other testing to consolidate work onto one instrument. Proposed tests that may be prioritised include (but are not limited to):
• Mycoplasma genitalium
• Influenza A
• Influenza B
• Chlamydia trachomatis and Neisseria gonorrhoeae (qualitative result) on both genital and non-genital samples (urines and swabs)
• Hepatitis B viral load (quantitative result) on plasma samples
The laboratory seeks to change the testing of these assays to a random access / continuous load instrument. In addition, it is proposed to also use the instrument for other testing to consolidate work onto one instrument. Proposed tests that may be prioritised include (but are not limited to):
• Mycoplasma genitalium
• Influenza A
• Influenza B
II.2.5)
Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)
Estimated value
Value excluding VAT: 2500000.00
EUR
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
60
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
Section III: Legal, economic, financial and technical information
III.1)
Conditions for participation
III.1.2)
Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3)
Technical and professional ability
Selection criteria as stated in the procurement documents
III.2)
Conditions related to the contract
Section IV: Procedure
IV.1)
Description
IV.1.1)
Type of procedure
Open procedure
IV.1.8)
Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement
: no
IV.2)
Administrative information
IV.2.2)
Time limit for receipt of tenders or requests to participate
Date:
27/04/2020
Local time:
12:00
IV.2.4)
Languages in which tenders or requests to participate may be submitted
English
IV.2.7)
Conditions for opening of tenders
Date:
27/04/2020
Local time:
12:00
Section VI: Complementary information
VI.1)
Information about recurrence
This is a recurrent procurement:
no
VI.2)
Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.4)
Procedures for review
VI.4.1)
Review body
The High Court
Dublin
Dublin
IE